How much Mounjaro should you take for weight loss?

Free consultation, no upfront payment, no hidden fee to see a prescriber
Same-day clinical review by a GPhC-registered Independent Prescriber, not an automated system
Once approved, treatment dispatched same day if ordered before 12pm Monday–Friday
Free next-working-day tracked delivery via DPD, in plain unbranded packaging, with aftercare seven days a week

The dose of Mounjaro you take for weight loss is decided by a GPhC-registered prescriber, not by the packet or a fixed rule. Treatment begins at 2.5mg — a tolerability starting point — and a clinician steps it upward, typically in four-week stages, until you reach the dose that works for you within the licensed 2.5mg–15mg range. Mounjaro (tirzepatide) is a prescription-only medicine, which means a qualified prescriber reviews your full health picture before any dose is set or changed. How much tirzepatide you should take for weight loss is never a decision to make from a forum or a price comparison; it belongs in a clinical conversation.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What private Mounjaro treatment actually costs, and why the dose tier matters

You've been told to start on 2.5mg, and you're wondering if you're getting the least effective version

Almost everyone asks some version of this. The 2.5mg pen is not a reduced-strength product for people who can't afford the real thing. Its job, per the licensed prescribing schedule, is to let your body adjust to tirzepatide before the dose increases. Nausea and other gastrointestinal effects are most noticeable in the first few weeks; starting low is how prescribers manage that. The therapeutic effect builds as the dose steps upward (5mg, 7.5mg, and so on) guided by how well you're tolerating each level and how your body is responding, and if you're curious about how much weight you should expect to lose on Mounjaro across that journey, we cover that in detail. You can read more about the full dosing trajectory on our Mounjaro dosing overview.

What this means practically: the dose you're on in month one is almost certainly not the dose you'll be on in month four. Prescribers titrate upward. So when you see private pricing quoted at a specific tier, it reflects the pen strength you're currently prescribed, and that changes. A provider quoting you only the starter-pen price may be giving you an incomplete picture of long-term cost.

The licensed range for weight management runs from 2.5mg to 15mg. The NICE appraisal of tirzepatide (TA1026) notes that if less than 5% body weight is lost after six months at the highest tolerated dose, continuing treatment should be reviewed. That review is a clinical decision, not one to shortcut.

What UK private pricing actually covers, and what it sometimes doesn't

Private Mounjaro pricing in the UK is quoted per pen, per month, or per dose tier. Since Eli Lilly raised its UK list price from 1 September 2025, typical private prices have ranged roughly £149 to £375 per month depending on the dose and provider, figures widely reported at the time of that change. Worth noting: the higher the dose, the higher the per-pen cost.

Headline figures from some providers cover the pen only. Consultation fees, prescription charges, delivery, and any follow-up clinical support may appear as separate line items, or not appear at all until checkout. A quick habit worth building: before committing to any provider, spend sixty seconds checking whether their quoted price includes a prescription, shipping, and access to a prescriber if you have questions mid-treatment. Those extras add up.

At nume, one price covers everything: free consultation, prescription, treatment, free next-working-day tracked delivery, and aftercare seven days a week. No subscription, no auto-renewal. Every repeat order goes back to a prescriber for clinical review before it's approved. We're transparent about what that model means: we don't position ourselves as the least expensive option. What you're paying for is clinical infrastructure, genuine supply chain, and the certainty that a real prescriber has looked at your case, not a pricing algorithm.

Current treatment pricing is listed on our Mounjaro price page, with no per-pen figures buried in the small print.

Why 'cheapest' is the wrong question for a prescription-only medicine

This isn't a lecture, it's a practical point. Mounjaro is a prescription-only medicine regulated by the MHRA. Sellers who offer it at prices well below the market rate, through social media channels or without requiring a clinical consultation, are a known problem. The MHRA has warned publicly about counterfeit tirzepatide pens entering the UK, including a raid on an illicit manufacturing site in 2025 and seizures of roughly 20 million doses of illegally traded weight-loss medicines worth around £45m. Fake pens have in some cases contained insulin, which is dangerous without a diabetes diagnosis.

The safe route is a pharmacy you can verify. Every legitimate online pharmacy in the UK appears on the GPhC register, you can check ours directly at the GPhC pharmacy register (registration 9012878). If a seller isn't on that list, that's the only answer you need.

Discount codes and vouchers for prescription medicines from unverified sellers are a specific red flag the MHRA has flagged. nume doesn't run discount codes. Not because we've forgotten to set one up, because a promotion tied to a prescription medicine isn't something a clinician-led service does. What we offer instead is a price that doesn't change based on a code you found on a forum, a consultation that's always free, and supply through the licensed UK chain. For more on what's included in treatment with us, the treatment overview has the full picture.

Questions about how much weight loss you can expect on Mounjaro are worth asking too, and if you want to understand what progress looks like at a specific stage, our pages on how much weight you should be losing on Mounjaro and what to expect on the 5mg dose in particular cover the evidence without overpromising.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions